Physician
Martin J Edelman, M.D.
According to 2025 Medicare claims, Martin Edelman, M.D. (NPI: 1437111978) practices hematopoietic cell transplantation and cellular therapy in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is TEMPLE FACULTY PRACTICE PLAN, INC (NPI: 1417430166; TIN: 831002191) and primary practice location at 19111-2434.
Edelman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 76 traditional Medicare patients, billed 315 HCPCS/CPT codes, and received $26,841 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 195 prescription claims across 38 beneficiaries totaling $1,220,812 in drug costs, led by Tagrisso (Osimertinib Mesylate). 2021 DME data shows 39 claims. Open Payments data shows 32 records totaling $46,816. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.
Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $37,698 and ending at $26,841. Concurrently, Part D prescription costs have risen steadily, from $2,101 to $1,220,812. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.